Posted by Sam Norman on Nov 28th, 2024
Aclaris Therapeutics, Inc. (NASDAQ:ACRS – Get Free Report) was the recipient of a significant drop in short interest in November. As of November 15th, there was short interest totalling 1,560,000 shares, a drop of 35.3% from...
More of this article »